Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol. 2009 Apr;65(4):403-13. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)		 Cohort
(N)		 Measurement
Mean ± SD		 Method;
Assay Name;
Manufacturer		 Diagnostic
Criteria
Aβ42
(CSF)		 AD
(100)		 144 ± 41
pg/mL		 xMAP;
AlzBio3;
Innogenetics		 McKhann et al., 1984
Aβ42
(CSF)		 CTRL-
CNC
(114)		 206 ± 55
pg/mL		 xMAP;
AlzBio3;
Innogenetics
tau-p181
(CSF)		 AD
(100)		 42 ± 20
pg/mL		 xMAP;
AlzBio3;
Innogenetics		 McKhann et al., 1984
tau-p181
(CSF)		 CTRL-
CNC
(114)		 25 ± 15
pg/mL		 xMAP;
AlzBio3;
Innogenetics
tau-total
(CSF)		 AD
(100)		 122 ± 58
pg/mL		 xMAP;
AlzBio3;
Innogenetics		 McKhann et al., 1984
tau-total
(CSF)		 CTRL-
CNC
(114)		 70 ± 30
pg/mL		 xMAP;
AlzBio3;
Innogenetics

Recommends

Please login to recommend the paper.

Comments

  1. I wonder whether the segregation power of this assay would be further strengthened if a marker of gliosis (GFAP, Iba1) or neuronal cell lysis (neurofilament) were added to the set.

    View all comments by Florian Muller

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. ADNI: GWA Nearly Complete, Biomarker Analysis Update
  2. Common Ground: Is Aβ the Foundation for Multiple Dementias?
  3. Still Early Days for α-synuclein Fluid Marker
  4. Triple Confirmation: AD Footprint in CSF of Cognitively Normal People
  5. Research Brief: Evidence Supports Model of AD Biomarker Progression
  6. CSF Testing for AD: Single-center Bliss, Multicenter Woe?
  7. Research Brief: How Normal Is Normal? ADNI Data Begs The Question
  8. Studies Reveal New Hope, Old Problems With AD Biomarkers
  9. Cerebrospinal Fluid Aβ Inches Closer to Bona Fide Diagnostic
  10. Living on the Edge: Moderately Low Aβ42 in CSF Predicts Decline
  11. What Goes Down Just Went Up: Aβ Climbs in Mouse CSF Before Dropping
  12. Polygenic Scores Paint Microglia as Culprits in Alzheimer's

Webinars

  1. Untapped Resource? New Study to Boost Acceptance of CSF Analysis

Research Timeline Event

  1. CSF Aβ/tau signature identifies prodromal AD within MCI cohorts, predicts cognitive decline

AlzBiomarker

  1. AD vs CTRL : Aβ42 (CSF)
  2. CTRL vs AD : Aβ42 (CSF)
  3. AD vs CTRL : tau-p181 (CSF)
  4. CTRL vs AD : tau-p181 (CSF)
  5. AD vs CTRL : tau-total (CSF)
  6. CTRL vs AD : tau-total (CSF)
AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics